BCL2 and diffuse large B-cell lymphoma: According to the 2016 WHO classification revision, patients with DH translocations should be excluded from the DLBCL NOS category and placed within the novel category “High-grade B-cell lymphomas, with MYC and BCL2 or BCL6 translocations”.